Low-Fat Breakfasts Could Weaken Effect of a Key Lung Cancer Drug
WEDNESDAY, June 14, 2023 (HealthDay News) — The lung cancer drug alectinib (Alecensa) is more potent when taken with a fuller breakfast, or lunch, than when taken with a low-fat breakfast, researchers report. The Dutch team evaluated 20 patients who took one of two daily doses of alectinib with eitherContinue Reading